Dr Alan Moodie joins GMEC Cluster Committee

10 Nov '11

Dr Alan Moodie will take over the role of representing GSK at the GMEC Cluster Committee, with immediate effect.

Alan is the Medicines Discovery & Development Operating Officer at GSK R&D and is accountable for delivering pipeline-enabling activities for the company’s discovery and development projects and for coordination of many of GSK R&D’s external engagement activities. He has over 20 years experience in the discovery, development and manufacturing of medicines. We look forward to working with Alan on GMEC projects and wish him every success in the role.